Lumasag, Venancia G.
HRN: 12-66-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2023
CEFTRIAXONE 1G (VIAL)
01/13/2023
01/19/2023
IV
2g
Od
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes